Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?

Clinical trial NCT04319328 · COMPLETED

Trial details

NCT number: NCT04319328
Sponsor: University of Manitoba
Status: COMPLETED
Study type: OBSERVATIONAL

Hemodialysis Complication Infectious Disease End Stage Renal Disease

Start date: 2019-10-18
Primary completion: 2024-04-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.